113 related articles for article (PubMed ID: 12181975)
21. Tropomyosin and dilated cardiomyopathy: revenge of the actinomyosin "gatekeeper".
Tardiff JC
J Am Coll Cardiol; 2010 Jan; 55(4):330-2. PubMed ID: 20117438
[No Abstract] [Full Text] [Related]
22. Sequential expression of genes involved in muscular dystrophies during human development.
Durand M; Suel L; Barbet JP; Beckmann JS; Fougerousse F
Morphologie; 2002 Jun; 86(273):9-12. PubMed ID: 12224393
[TBL] [Abstract][Full Text] [Related]
23. [X-linked dilated cardiomyopathy: a cardiospecific phenotype of dystrophinopathy].
Yoshida K; Takeda S
Ryoikibetsu Shokogun Shirizu; 2001; (35):23-7. PubMed ID: 11555918
[No Abstract] [Full Text] [Related]
24. Gene symbol: CMD1A. Disease: Dilated cardiomyopathy associated with conduction system disease.
Arbustini EA; Pasotti M; Pilotto A; Repetto A; Grasso M; Diegoli M
Hum Genet; 2005 Jul; 117(2-3):295. PubMed ID: 16156018
[No Abstract] [Full Text] [Related]
25. Specific assembly pathway of sarcoglycans is dependent on beta- and delta-sarcoglycan.
Shi W; Chen Z; Schottenfeld J; Stahl RC; Kunkel LM; Chan YM
Muscle Nerve; 2004 Mar; 29(3):409-19. PubMed ID: 14981741
[TBL] [Abstract][Full Text] [Related]
26. A novel mechanism of myocyte degeneration involving the Ca2+-permeable growth factor-regulated channel.
Iwata Y; Katanosaka Y; Arai Y; Komamura K; Miyatake K; Shigekawa M
J Cell Biol; 2003 Jun; 161(5):957-67. PubMed ID: 12796481
[TBL] [Abstract][Full Text] [Related]
27. Characterization of the canine desmin (DES) gene and evaluation as a candidate gene for dilated cardiomyopathy in the Dobermann.
Stabej P; Imholz S; Versteeg SA; Zijlstra C; Stokhof AA; Domanjko-Petric A; Leegwater PA; van Oost BA
Gene; 2004 Oct; 340(2):241-9. PubMed ID: 15475165
[TBL] [Abstract][Full Text] [Related]
28. Epsilon-sarcoglycan mutations found in combination with other dystonia gene mutations.
Klein C; Liu L; Doheny D; Kock N; Müller B; de Carvalho Aguiar P; Leung J; de Leon D; Bressman SB; Silverman J; Smith C; Danisi F; Morrison C; Walker RH; Velickovic M; Schwinger E; Kramer PL; Breakefield XO; Brin MF; Ozelius LJ
Ann Neurol; 2002 Nov; 52(5):675-9. PubMed ID: 12402271
[TBL] [Abstract][Full Text] [Related]
29. Frequency and clinical characteristics of dilated cardiomyopathy caused by desmin gene mutation in a Japanese population.
Miyamoto Y; Akita H; Shiga N; Takai E; Iwai C; Mizutani K; Kawai H; Takarada A; Yokoyama M
Eur Heart J; 2001 Dec; 22(24):2284-9. PubMed ID: 11728149
[TBL] [Abstract][Full Text] [Related]
30. The genetics of dilated cardiomyopathy--emerging clues to the puzzle.
Leiden JM
N Engl J Med; 1997 Oct; 337(15):1080-1. PubMed ID: 9321539
[No Abstract] [Full Text] [Related]
31. Gene symbol: LMNA. Disease: Cardiomyopathy, dilated, with conduction defect 1.
Arbustini Eloisa AE; Pilotto A; Pasotti M; Grasso M; Diegoli M; Campana C; Gavazzi A; Alessandra R; Tavazzi L
Hum Genet; 2005 Jul; 117(2-3):298. PubMed ID: 16156025
[No Abstract] [Full Text] [Related]
32. Lamin A/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement.
Schmidt HH; Lochs H
Circulation; 2001 Jan; 103(4):E20. PubMed ID: 11157732
[No Abstract] [Full Text] [Related]
33. Two related Dutch families with a clinically variable presentation of cardioskeletal myopathy caused by a novel S13F mutation in the desmin gene.
Bergman JE; Veenstra-Knol HE; van Essen AJ; van Ravenswaaij CM; den Dunnen WF; van den Wijngaard A; van Tintelen JP
Eur J Med Genet; 2007; 50(5):355-66. PubMed ID: 17720647
[TBL] [Abstract][Full Text] [Related]
34. Gene symbol: LMNA. Disease: Cardiomyopathy, dilated, with conduction tissue defect 1.
Arbustini Eloisa AE; Pilotto A; Porcu E; Landolina M; Pasotti M; Lucchelli C; Disabella E; Tavazzi L
Hum Genet; 2005 Jul; 117(2-3):300. PubMed ID: 16156034
[No Abstract] [Full Text] [Related]
35. Immunocytochemical study of cytoskeletal proteins in centronuclear myopathies.
Manta P; Mamali I; Zambelis T; Aquaviva T; Kararizou E; Kalfakis N
Acta Histochem; 2006; 108(4):271-6. PubMed ID: 16893562
[TBL] [Abstract][Full Text] [Related]
36. Risk Stratification in Patients With Nonisquemic Dilated Cardiomyopathy. The Role of Genetic Testing.
Peña-Peña ML; Monserrat L
Rev Esp Cardiol (Engl Ed); 2019 Apr; 72(4):333-340. PubMed ID: 30792015
[TBL] [Abstract][Full Text] [Related]
37. Thymopoietin (lamina-associated polypeptide 2) gene mutation associated with dilated cardiomyopathy.
Taylor MR; Slavov D; Gajewski A; Vlcek S; Ku L; Fain PR; Carniel E; Di Lenarda A; Sinagra G; Boucek MM; Cavanaugh J; Graw SL; Ruegg P; Feiger J; Zhu X; Ferguson DA; Bristow MR; Gotzmann J; Foisner R; Mestroni L;
Hum Mutat; 2005 Dec; 26(6):566-74. PubMed ID: 16247757
[TBL] [Abstract][Full Text] [Related]
38. Functional nitric oxide synthase mislocalization in cardiomyopathy.
Heydemann A; Huber JM; Kakkar R; Wheeler MT; McNally EM
J Mol Cell Cardiol; 2004 Feb; 36(2):213-23. PubMed ID: 14871549
[TBL] [Abstract][Full Text] [Related]
39. [Diseases associated with lamin A/C gene defects: what the clinical cardiologist ought to know].
Pasotti M; Repetto A; Pisani A; Arbustini E
Ital Heart J Suppl; 2004 Feb; 5(2):98-111. PubMed ID: 15080529
[TBL] [Abstract][Full Text] [Related]
40. X-linked dilated cardiomyopathy.
Towbin JA; Ortiz-Lopez R
N Engl J Med; 1994 Feb; 330(5):369-70. PubMed ID: 8123157
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
